Suppr超能文献

从未经处理的骨髓中快速大规模扩增功能性间充质干细胞,无需动物血清。

Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.

作者信息

Schallmoser Katharina, Rohde Eva, Reinisch Andreas, Bartmann Christina, Thaler Daniela, Drexler Camilla, Obenauf Anna C, Lanzer Gerhard, Linkesch Werner, Strunk Dirk

机构信息

Stem Cell Research Unit, Medical University of Graz, Graz, Austria.

出版信息

Tissue Eng Part C Methods. 2008 Sep;14(3):185-96. doi: 10.1089/ten.tec.2008.0060.

Abstract

Adult mesenchymal stem cells (MSCs) are considered as valuable mediators for tissue regeneration and cellular therapy. This study was performed to develop conditions for regularly propagating a clinical quantity of > 2 x 10(8) MSCs without animal serum from small bone marrow (BM) aspiration volumes within short time. We established optimized culture conditions with pooled human platelet lysate (pHPL) replacing fetal bovine serum (FBS) for MSC propagation. MSC quality, identity, purity, and function were assessed accordingly. Biologic safety was determined by bacterial/fungal/mycoplasma/endotoxin testing and genomic stability by array comparative genomic hybridization (CGH). We demonstrate that unmanipulated BM can be used to efficiently initiate MSC cultures without the need for cell separation. Just diluting 1.5-5 mL heparinized BM per 500 mL minimum essential medium supplemented with L-glutamine, heparin, and 10% pHPL sufficiently supported the safe propagation of 7.8 +/- 1.5 x 10(8) MSCs within a single 11- to 16-day primary culture under defined conditions. This procedure also resulted in sustained MSC colony recovery. MSC purity, immune phenotype, and in vitro differentiation potential fully matched current criteria. Despite high proliferation rate, MSCs showed genomic stability in array CGH. This easy single-phase culture procedure can build the basis for standardized manufacturing of MSC-based therapeutics under animal serum-free conditions for dose-escalated cellular therapy and tissue engineering.

摘要

成人间充质干细胞(MSCs)被认为是组织再生和细胞治疗的重要介质。本研究旨在开发在短时间内从小体积骨髓抽吸物中无动物血清常规扩增临床数量(> 2×10⁸)MSCs的条件。我们建立了优化的培养条件,用人血小板裂解物(pHPL)替代胎牛血清(FBS)来扩增MSCs。相应地评估了MSCs的质量、特性、纯度和功能。通过细菌/真菌/支原体/内毒素检测确定生物安全性,通过阵列比较基因组杂交(CGH)确定基因组稳定性。我们证明未经处理的骨髓可用于高效启动MSCs培养,无需细胞分离。在补充有L-谷氨酰胺、肝素和10% pHPL的每500 mL最低限度基本培养基中仅稀释1.5 - 5 mL肝素化骨髓,就足以在限定条件下的单次11至16天原代培养中安全扩增7.8±1.5×10⁸个MSCs。该方法还能持续恢复MSCs集落。MSCs的纯度、免疫表型和体外分化潜能完全符合当前标准。尽管增殖率高,但MSCs在阵列CGH中显示出基因组稳定性。这种简单的单相培养方法可为在无动物血清条件下标准化生产基于MSCs的治疗药物奠定基础,用于剂量递增的细胞治疗和组织工程。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验